News & Perspective

Oct 01, 2019

Oct 01, 2019

News Scan for Oct 01, 2019

More DRC Ebola
Universal flu vaccine network launch
Passive immunity for flu
Zoonotic flu vaccine strain
Basil-linked Cyclospora
US bio-, agro-defense center head

Sep 16, 2019

Sep 16, 2019
HHS Secretary Azar Ebola

US officials end visit to DRC Ebola region; cases rise to 3,129

US officials said other outbreak indicators such as deaths in the community need to improve before they feel more confident about the recent drop in cases.

Aug 20, 2019

Aug 20, 2019

News Scan for Aug 20, 2019

More DRC Ebola cases
Flu lingering in Australia
Broadly protective flu patch
Fast-tracked Zika vaccine

Aug 12, 2019

Aug 12, 2019
Alima cube

Ebola outbreak treatment trial narrowed to two promising drugs

Officials hope the promising treatment findings encourage more patients to seek lifesaving treatment.

Aug 01, 2019

Aug 01, 2019
DRC PPE

Two new cases in Goma as DRC Ebola outbreak reaches 1-year mark

In other developments, the WHO said Beni is still the main hot spot and that the pace of new infections hasn't changed much.

Apr 03, 2019

Apr 03, 2019
Community Ebola representatives in DR Congo

DRC Ebola total hits 1,100; study targets secondary spread

Admission to an Ebola treatment unit was tied to a 38% drop in secondary cases.

Jan 29, 2019

Jan 29, 2019
DR Congo women

Katwa remains outbreak hot spot as Ebola cases reach 743

Four of the 7 new cases were reported in Katwa, the latest outbreak hot spot.

Oct 30, 2018

Oct 30, 2018
ebola vaccine

Ebola total hits 276 as lasting effect noted for 3 vaccines

Immune response lasted 2.5 years for the vaccines, the longest yet in ongoing studies of Ebola immunization.

Aug 14, 2017

Aug 14, 2017

News Scan for Aug 14, 2017

MERS case
Multidrug-resistant BSIs in India
Polio emergency continues
Ricin vaccine funding
Chikungunya in the Americas

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»